Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

I think as long as we see a good 1QE showing strong Focalin sales

There won't be any Focalin sales revenue on that report outside of the usual ~ $600,000 for the 15mg and 30mg sales.

PAR's 1st quarter which will contain sales of the paragraph 4 25mg and 35mg doses doesn't end until March 31st and royalties are not due until April 30th.

IPCI's 1st Qtr report on April 10th will not contain any of the 180 day exclusivity doses... and more than likely won't even have sales figures for it.